Tim Collins provides clients with mixed-methods research and data analysis services to help them understand the impacts of federal policies on the healthcare industry and its stakeholders.
Before joining Avalere, Tim served as a research consultant at the Lewin Group, where he worked as a mixed-methods researcher evaluating the Bundled Payments for Care Improvement Advanced Model. He gained expertise in various research and data analysis methods, including comparison group development, regression analysis, qualitative interviewing, and economic report writing.
Tim holds a BA in economics from Vassar College.
Authored Content
This paper details the financial impact to employers on health system consolidation, using the Chicago healthcare market as a case study.
Avalere Health finds opioid use disorder costs businesses, governments, and households almost $1 trillion per year, but treatment with medications can lower costs.
Across three therapeutic areas, an Avalere Health analysis identified commercial plan coverage policies with more steps than indicated by drugs’ FDA labels.
Across physician specialties, Medicare utilization and reimbursement data shows that site-of-care optimization can reduce expenditures for certain healthcare services.
Analysis of Part D plans including step therapy in prior authorization and the frequency of step therapy criteria that include steps beyond the drugs’ FDA labels.
Overall coverage of MS drugs among Part D plans declined by six percentage points, from 49% of the time across all plans and drugs analyzed in 2024 to 43% in 2025.
An Avalere analysis assessing differences in Medicare expenditures and utilization across 4 models provides a new perspective on the evolving physician affiliation model landscape.